This Government Contract opportunity from Department Of Health And Human Services was posted on April 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source – Agilent Technologies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center, Department of Transfusion Medicine, intends to award a sole source fixed price purchase order to Agilent Technologies for the Agilent SureScan Microarray Scanner, essential for ongoing clinical research on hepatitis viruses and other transfusion-transmissible pathogens. The scanner is required due to its unique compatibility with existing Agilent microarray platforms and patented multiviral detection workflows, which no other manufacturer can match. Its dual-laser scanning system, optimized for Cy3 and Cy5 dyes, high sensitivity for low-abundance nucleic acids, and built-in ozone protection are critical technical features not replicable by alternative systems without compromising data accuracy and workflow integrity. The laboratory’s established protocols, staff training, and bioinformatics pipelines are all built around Agilent technology, making a transition to another platform impractical without extensive revalidation and disruption. This acquisition is being conducted under FAR Part 13 Simplified Acquisition Procedures, allowing a sole source award because Agilent is the only vendor capable of fulfilling the specific technical and compatibility requirements. The purchase falls under the simplified acquisition threshold and is exempt from full competition requirements. The instrument will be delivered and installed at the NIH facility in Bethesda, Maryland, and the procurement is identified under Product Service Code 6515 and NAICS Code 339112. Interested parties may submit comments or express interest prior to the deadline of May 5, 2026, at 11 a.m. EST, addressed to Kristin Nagashima, Contract Specialist at NIH, but no formal solicitation or quotation request will be issued. The decision not to compete the requirement rests solely with the government.
General Info
Agency
NAICS
Place of Performance
MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The National Institutes of Health (NIH) Clinical Center (CC), Department of Transfusion Medicine (DTM), Infectious Diseases Section requires acquisition of the Agilent SureScan Microarray Scanner, including all necessary hardware, proprietary software, and installation components required for operation to support ongoing clinical research and development of diagnostic assays for hepatitis viruses and other transfusion-transmissible pathogens.
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-005071
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Agilent Technologies, located at 121 Hartwell Ave, Lexington, MA 02421, on a firm fixed price sole source award basis to provide Accreditation on-site evaluation services to the National Institutes of Health.
The Agilent SureScan Microarray Scanner is uniquely qualified to meet the NIH Clinical Center, Department of Transfusion Medicine (DTM), Infectious Diseases Section’s technical and compatibility requirements for the following reasons:
• Proprietary Compatibility: The scanner is specifically designed to integrate with Agilent microarray platforms and associated feature extraction software currently in use within the laboratory. No other manufacturer provides full compatibility with existing Agilent microarray slides and validated workflows. A customize Microarray platform for multiviral detection has been patented and the Agilent scanner is the only solution available for reading the post hybridization fluorescence.
• Data Continuity and Integrity: Ongoing research projects rely on previously generated datasets using Agilent systems. Introducing a different scanner would create variability in data acquisition, compromising longitudinal studies and reproducibility.
• Unique Technical Capabilities: Dual-laser scanning with optimized wavelengths for Cy3 and Cy5 dyes; High sensitivity required for low-abundance nucleic acid detection; Built-in ozone protection to preserve fluorescence signal integrity; These features are critical and not equivalently available in alternative systems without significant compromise.
• Workflow Integration: Existing laboratory protocols, staff training, and bioinformatics pipelines are specifically configured for Agilent platforms. Transitioning to another system would require substantial retraining, method revalidation, and workflow disruption.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by May 5, 2026 at 11am EST.
More opportunities from Department Of Health And Human Services → National Institutes Of Health - Cc
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
